OptiNose's Series E Round

OptiNose raised a round of funding on April 07, 2017.

OptiNose is a specialty pharmaceutical company built around a unique nasal delivery platform. The company is driven by an experienced, world-class team with expertise including drug and device develop…

Articles about OptiNose's Series E Round: